Maravai LifeSciences Holdings, Inc. Total Long-Term Debt
Maravai LifeSciences Holdings, Inc. (MRVI) had Total Long-Term Debt of $147.10 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebt · last filed 2026-08-07
- 2026-06-30: Long-term Debt $147.10M.
- 2026-03-31: Long-term Debt $241.01M.
- 2025-12-31: Long-term Debt $291.77M.
- 2025-09-30: Long-term Debt $292.82M.
| Period end | Long-term Debt |
|---|---|
| 2026-06-30 | $147.10M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $241.01M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $291.77M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $292.82M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $293.88M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $294.94M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $295.93M 10-K · filed 2026-02-26 |
| 2024-09-30 | $521.72M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $522.52M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $523.33M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $524.15M 10-K · filed 2025-03-18 |
| 2023-09-30 | $524.96M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $525.78M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $526.60M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $527.44M 10-K · filed 2024-02-29 |
| 2022-09-30 | $528.26M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $529.10M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $529.94M 10-Q · filed 2022-05-06 |
| 2022-01-31 | $544.00M 10-K · filed 2023-02-28 |
| 2021-12-31 | $530.59M 10-K · filed 2023-02-28 |
| 2021-09-30 | $531.58M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $532.58M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $533.59M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $534.61M 10-K · filed 2022-03-01 |
| 2020-10-31 | $400.00M 10-K · filed 2023-02-28 |